Literature DB >> 12968090

Clinical practice. Early Alzheimer's disease.

Claudia H Kawas1.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12968090     DOI： 10.1056/NEJMcp022295

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  22 in total

1.  Selection of aptamers for amyloid beta-protein, the causative agent of Alzheimer's disease.

Authors:  Farid Rahimi; Gal Bitan
Journal:  J Vis Exp       Date:  2010-05-13       Impact factor: 1.355

2.  Four sensitive screening tools to detect cognitive dysfunction in geriatric emergency department patients: brief Alzheimer's Screen, Short Blessed Test, Ottawa 3DY, and the caregiver-completed AD8.

Authors:  Christopher R Carpenter; Elizabeth R Bassett; Grant M Fischer; Jonathan Shirshekan; James E Galvin; John C Morris
Journal:  Acad Emerg Med       Date:  2011-04       Impact factor: 3.451

3.  [Statement to the preliminary report of the IQWiG A05-19B ginkgo-containing preparation at Alzheimers dementia].

Authors:  Manfred Gogol; Dieter Lüttje; Cornel Sieber; Hansjörg Werner
Journal:  Z Gerontol Geriatr       Date:  2007-08       Impact factor: 1.281

Review 4.  Genetics of Alzheimer disease.

Authors:  Lynn M Bekris; Chang-En Yu; Thomas D Bird; Debby W Tsuang
Journal:  J Geriatr Psychiatry Neurol       Date:  2010-12       Impact factor: 2.680

Review 5.  Protein aggregation in the brain: the molecular basis for Alzheimer's and Parkinson's diseases.

Authors:  G Brent Irvine; Omar M El-Agnaf; Ganesh M Shankar; Dominic M Walsh
Journal:  Mol Med       Date:  2008 Jul-Aug       Impact factor: 6.354

6.  Prenatal antidepressant exposure associated with CYP2E1 DNA methylation change in neonates.

Authors:  Cécile Gurnot; Ignacio Martin-Subero; Sarah M Mah; Whitney Weikum; Sarah J Goodman; Ursula Brain; Janet F Werker; Michael S Kobor; Manel Esteller; Tim F Oberlander; Takao K Hensch
Journal:  Epigenetics       Date:  2015-04-18       Impact factor: 4.528

7.  The emergence of Ephexin5 as a therapeutic target in Alzheimer's disease.

Authors:  Emily K Cook; Gabrielle L Sell; Thomas B Schaffer; Seth S Margolis
Journal:  Expert Opin Ther Targets       Date:  2019-03-05       Impact factor: 6.902

8.  Alzheimer's disease: a healthcare burden of epidemic proportion.

Authors:  T S Dharmarajan; Srinivas G Gunturu
Journal:  Am Health Drug Benefits       Date:  2009-01

9.  Reducing expression of synapse-restricting protein Ephexin5 ameliorates Alzheimer's-like impairment in mice.

Authors:  Gabrielle L Sell; Thomas B Schaffer; Seth S Margolis
Journal:  J Clin Invest       Date:  2017-03-27       Impact factor: 14.808

10.  Alzheimer's disease: synaptic dysfunction and Abeta.

Authors:  Ganesh M Shankar; Dominic M Walsh
Journal:  Mol Neurodegener       Date:  2009-11-23       Impact factor: 14.195
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.